Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001292617 | SCV001481205 | uncertain significance | Fanconi anemia complementation group A | 2020-09-11 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV001859237 | SCV002139809 | benign | Fanconi anemia | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001859237 | SCV002535041 | uncertain significance | Fanconi anemia | 2021-08-10 | criteria provided, single submitter | curation | |
St. |
RCV001292617 | SCV005402122 | uncertain significance | Fanconi anemia complementation group A | 2024-04-11 | criteria provided, single submitter | clinical testing | The FANCA c.4177G>A (p.Val1393Met) missense change has a maximum subpopulation frequency of 0.03% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). The in silico tool REVEL is inconclusive about a pathogenic or benign effect of this variant on protein function, and functional studies have not been performed. This variant has not been reported in individuals with Fanconi anemia. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. |